Sort
85,873 grants matching “alzheimers”
Role of estradiol and related hormones on inflammation, sleep, and risks for Alzheimer's disease
$752,513Whitney Lee Wharton · Emory University · R01 · FY2019 · AG
Role of PDE2A in mitochondrial dysfunction in Alzheimerâs disease
$752,468Ying Xu · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System
$752,464Evaristus A Nwulia · Howard University · R01 · FY2020 · AG
Creating a region- specific biomolecular atlas of the brain of Alzheimerâs disease
$752,438Lingjun Li · University Of Wisconsin-Madison · R01 · FY2023 · AG
Contribution of AD genetic risk and microglial BIN1 to tauopathy
$752,411Nicole Gabriele Coufal · University Of California, San Diego · R01 · FY2025 · AG
A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer
$752,394Ihab M Hajjar · Emory University · R01 · FY2016 · AG
Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy
$752,390S. Ali Fatemi · Hugo W. Moser Res Inst Kennedy Krieger · R61 · FY2025 · NS
Role of Neurotrophins in the Development of the Mammalian Nervous System
$752,388Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Natural History of Amyloid Deposition in adults with Down Syndrome
$752,386Benjamin L Handen · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AG
Air Pollution and Alzheimer's Dementia: Neuropathologic and Olfactory Mechanisms in Multi-Ethnic Longitudinal Cohorts
$752,385Jennifer Weuve · Boston University Medical Campus · R01 · FY2021 · AG
Ã-hydroxybutyrate inhibition of pathology in Alzheimer's disease
$752,364Tyler Kent Ulland · University Of Wisconsin-Madison · R01 · FY2023 · AG
Ã-hydroxybutyrate inhibition of pathology in Alzheimer's disease
$752,364Tyler Kent Ulland · University Of Wisconsin-Madison · R01 · FY2024 · AG
Standardizing and Harmonizing Behavioral and Social Science Research Factors in Alzheimer's Disease through Ontology-Based Approaches
$752,353Cui Tao · Mayo Clinic Jacksonville · U01 · FY2025 · AG
PASK-regulated genes and proteins as therapeutic targets for ALS and FTD
$752,319Daniel R Scoles · University Of Utah · R01 · FY2024 · NS
Effects of tDCS on spoken and written production in Primary Progressive Aphasia
$752,315Kyrana Tsapkini · Johns Hopkins University · R01 · FY2016 · DC
The risks and consequences of a motor vehicle crash in older adults with Alzheimer's Disease and Related Dementias
$752,293Nina Joyce · Brown University · R01 · FY2024 · AG
Predictors of Severity in Alzheimer's Disease
$752,289Yaakov Stern · Columbia University Health Sciences · R01 · FY2013 · AG
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial
$752,288Barry W Rovner · Thomas Jefferson University · R01 · FY2022 · AG
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain
$752,280Shaoqin - Gong · University Of Wisconsin-Madison · UG3 · FY2018 · NS
Sleep Fragmentation and Alzheimerâs Disease
$752,277Michael Paul Murphy · University Of Kentucky · R01 · FY2021 · AG
Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons
$752,246Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2018 · ES
T cells in the aging brain
$752,242Anne Brunet · Stanford University · R01 · FY2021 · AG
Blood Base Bioenergetic Profiling: A Novel Approach for Identifying Alzheimer's Disease Risk and Pathology
$752,198Barbara J Nicklas · Wake Forest University Health Sciences · R01 · FY2020 · AG
Cocoa Supplement and Multivitamin Outcomes Study in the Mind (COSMOS-Mind)
$752,194Laura D. Baker · Wake Forest University Health Sciences · R01 · FY2019 · AG
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease
$752,185Andrei G. Vlassenko · Washington University · R01 · FY2018 · AG